Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry

Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients with Atopic Dermatitis: 2-Year Interim Data from the PROSE Registry

Abstract Introduction There is a scarcity of data beyond 1 year for the use of dupilumab to treat atopic dermatitis (AD) in a real-world setting. This study aimed to evaluate the 2-year effectiveness of dupilumab among adult and pediatric patients with moderate-to-severe AD included in a real-world,...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Eric L. Simpson, Ben Lockshin, Lara Wine Lee, Zhen Chen, Moataz Daoud, Andrew Korotzer
Materialtyp: Artikel
Språk:English
Publicerad: Adis, Springer Healthcare 2024-01-01
Serie:Dermatology and Therapy
Ämnen:
Atopic dermatitis
Disease control
Dupilumab
Efficacy
Health-related quality of life
Patient-reported outcomes
Länkar:https://doi.org/10.1007/s13555-023-01061-4

Internet

https://doi.org/10.1007/s13555-023-01061-4

Liknande verk